Clinical Trial Update: Immunogenicity and Safety of GSK Biologicals' Live Attenuated Varicella Vaccine (VARILRIXTM). [Phase 2]

View source ↗

Summary

A Phase 2 trial update on the immunogenicity and safety of GlaxoSmithKline's live attenuated varicella vaccine VARILRIX, with completed status and results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Varicella

Drugs mentioned

• Varilrix (varicella vaccine (live attenuated))

Snippet

Sponsor: GlaxoSmithKline | Conditions: Varicella | Phase 2 | Status: COMPLETED | Results posted: 2017-07-06